Reference SummaryDen Engelse L, Eur J Cancer 1976 Feb;12(2):101-6

Title

 Hepatomas in GRS/A male mice treated with horse serum or horse anti-mouse antilymphocyte serum.

Authors

 Den Engelse L; Misdorp W; Emmelot P

Journal

 Eur J Cancer

Volume

 12

Issue

 2

Year

 1976

Pages

 101-6

Abstract

Links

 J:24630 – MGI References
177290 – National Library of Medicine/PubMed

Models
Strain Model Name Treatment Agent(s) Organ Affected Frequency Model Details
GRS/A Adipose tissue lipoma Adipose tissue

1.1
GRS/A Adipose tissue lipoma
  • normal horse serum (NHS)
 Adipose tissue

2.7
GRS/A Adipose tissue lipoma
  • horse anti-mouse anitlymphocyte serum (HALS)
 Adipose tissue

3.0
GRS/A Leukocyte leukemia Leukocyte

5.7
GRS/A Liver hepatoma
  • horse anti-mouse anitlymphocyte serum (HALS)
 Liver

0 - 28
GRS/A Liver hepatoma
  • normal horse serum (NHS)
 Liver

2.4 - 35
GRS/A Liver hepatoma Liver

3.2
GRS/A Lung adenoma
  • horse anti-mouse anitlymphocyte serum (HALS)
 Lung

20 - 28
GRS/A Lung adenoma
  • normal horse serum (NHS)
 Lung

17 - 47
GRS/A Lung adenoma Lung

14
GRS/A Mammary gland adenocarcinoma Mammary gland

1.1
GRS/A Skin - Hair follicle - Basal cell trichoepithelioma Skin - Hair follicle - Basal cell

1.1
GRS/A Skin squamous cell carcinoma - well differentiated
  • normal horse serum (NHS)
 Skin

0.7
GRS/A (Unspecified organ) papilloma (Unspecified organ)

1.1